Investigating glatiramer acetate for relapsing-remitting multiple sclerosis at the double dose--is more better?
Calabresi
Peter A
PA
Johns Hopkins Multiple Sclerosis Center, Baltimore, MD, USA. pcalabr1@jhmi.edu